Zi-Huan Zhang

Dr. Zi-Huan Zhang

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
QCQiang Chen
Qiang Chen
ZYZhen-Nan Ye
Zhen-Nan Ye
JLJing-Peng Liu
Jing-Peng Liu
ZZZi-Huan Zhang
Zi-Huan Zhang
CZChen-Hui Zhou
Chen-Hui Zhou
CHChun-Hua Hang
Chun-Hua Hang

1 June 2024 in HepatoBiliary Surgery and Nutrition
Verified
Journal Article
Open access
PDF file
DLDuo Li
Duo Li
LXLi Xu
Li Xu
XDXiangling Deng
Xiangling Deng
YSYongliang Sun
Yongliang Sun
ZZZi-Huan Zhang
Zi-Huan Zhang
ZYZhiying Yang
Zhiying Yang
Background: Concerns over the security of laparoscopic radical operation for gallbladder cancer (GBC) persist. This systematic review and meta-analysis attempted to compare the safety and efficacy of laparoscopic surgery (LS) versus open surgery (OS) in the treatment of GBC. Methods: The PubMed, EMBASE, and Web of Science were searched from inception to July 18, 2022. Literature search, quality assessment, and data extraction were completed independently and in duplicate. Effect-size estimates expressed as weighted mean difference (WMD) or odds ratio (OR) with 95% confidence interval (CI) were derived under the random-effects model. Results: A total of 27 independent studies including 2,868 participants were meta-analyzed. Significance was noted for intraoperative blood loss (WMD: −117.194, 95% CI: −170.188 to 64.201, P<0.001), harvested lymph nodes (WMD: −1.023, 95% CI: −1.776 to −0.269, P=0.008), postoperative hospital stay (WMD: −3.555, 95% CI: −4.509 to −2.601, P<0.001), postoperative morbidity (OR: 0.596, 95% CI: 0.407 to 0.871, P=0.008), overall survival rate at 2-year (OR: 1.524, 95% CI: 1.143 to 2.031, P=0.004), T2 survival at 1-year (OR: 1.799, 95% CI: 1.777 to 2.749, P<0.01) and 2-year (OR: 2.026, 95% CI: 1.392 to 2.949, P<0.001), as well as T3 survival at 1-year (OR: 2.669, 95% CI: 1.564 to 4.555, P<0.001) and 2-year (OR: 2.300, 95% CI: 1.308 to 4.046, P=0.004). Subgroup analyses revealed that ethnicity, incidental GBC, sample size, and follow-up period were possible sources of heterogeneity. There was a low probability of publication bias for all outcomes except postoperative morbidity. Conclusions: Our findings indicated that LS statistically had better 2-year survival rates, less intraoperative bleeding, shorter hospitalization times, and lower rates of complications than OS. However, the superiority and even the safety of LS still remain an open question due to the impact of incidental GBC, unaccounted heterogeneity, publication bias, lymph node dissection, and port-site metastasis.

5 January 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ZZZi-Huan Zhang
Zi-Huan Zhang
DLDuo Li
Duo Li
TWTianxiao Wang
Tianxiao Wang
HNHeyuan Niu
Heyuan Niu
Wenquan NiuWenquan Niu
Wenquan Niu
ZYZhiying Yang
Zhiying Yang
Backgrounds: Concomitant abdominal aortic aneurysms (AAA) and gastrointestinal malignancies are uncommon. Endovascular repair (EVAR) is widely used to treat AAA. However, no consensus exists on the optimal strategy for treating AAA when associated with pancreatic adenocarcinoma. In addition, only few reports of pancreaticoduodenectomy (PD) after EVAR exist. Presentation of case: A pancreatic tumor was detected during follow-up after EVAR for AAA in an 83-year-old female patient. The diagnosis was high-grade intraepithelial neoplasia. Modified pylorus-preserving pancreaticoduodenectomy was safely performed. The patient recovered moderately and was discharged two weeks after surgery. The pathological diagnosis was middle-grade pancreatic ductal adenocarcinoma. The patient survived for 24 months with no recurrence or cardiovascular complications. Conclusions: Conducting periodic follow-ups after AAA surgery is helpful for the early discovery of gastrointestinal tumors. EVAR surgery is safe and feasible and thus recommended for AAA patients with pancreatic cancer, although it may increase the risk of cancer. The stage of malignancy and post-EVAR medical history can be valuable in evaluating the benefits of pancreatic surgery for such cases.